ABBV-8E12

ABBV-8E12 · AbbVie

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ABBV-8E12, covering 2021-02-03 to 2022-09-22. Get the full timeline:

Most recent: Clinical Trial Update: An Extension Study of ABBV-8E12 in Early Alzheimer's Disease (AD) [Phase 2]